Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 13, 2016
Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors
Ludmila Danilova, Hao Wang, Joel Sunshine, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 10, 2016
Enrichment of Scleroderma Vascular Disease-Associated Autoantigens in Endothelial Lineage Cells
Zsuzsanna H McMahan, Tricia R Cottrell, Fredrick M Wigley, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 2, 2017
Implications of the tumor immune microenvironment for staging and therapeutics
Janis M Taube, Jérôme Galon, Lynette M Sholl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2017
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison
Joel C Sunshine, Peter L Nguyen, Genevieve J Kaunitz, et al.
JAMA Oncology
|
March 24, 2017
Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy
Elizabeth L Yanik, Genevieve J Kaunitz, Tricia R Cottrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2019
Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade
Julie E Stein, Evan J Lipson, Tricia R Cottrell, et al.
Journal for Immunotherapy of Cancer
|
June 20, 2020
Chronic immune checkpoint inhibitor pneumonitis
Jarushka Naidoo, Tricia R Cottrell, Evan J Lipson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
July 25, 2017
Melanoma subtypes demonstrate distinct PD-L1 expression profiles
Genevieve J Kaunitz, Tricia R Cottrell, Mohammed Lilo, et al.
Eclinicalmedicine
|
December 31, 2024
Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trial
Abha A Gupta, Anna Tinker, Derek Jonker, et al.
Journal for Immunotherapy of Cancer
|
December 25, 2025
AstroID resource: a scalable, relational database structure for longitudinal biomarker discovery
Elizabeth M Will, Benjamin F Green, Scott Carey, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Proceedings of the National Academy of Sciences of the United States of America
|
November 13, 2016
Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors
Ludmila Danilova, Hao Wang, Joel Sunshine, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 10, 2016
Enrichment of Scleroderma Vascular Disease-Associated Autoantigens in Endothelial Lineage Cells
Zsuzsanna H McMahan, Tricia R Cottrell, Fredrick M Wigley, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 2, 2017
Implications of the tumor immune microenvironment for staging and therapeutics
Janis M Taube, Jérôme Galon, Lynette M Sholl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2017
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison
Joel C Sunshine, Peter L Nguyen, Genevieve J Kaunitz, et al.
JAMA Oncology
|
March 24, 2017
Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy
Elizabeth L Yanik, Genevieve J Kaunitz, Tricia R Cottrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2019
Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade
Julie E Stein, Evan J Lipson, Tricia R Cottrell, et al.
Journal for Immunotherapy of Cancer
|
June 20, 2020
Chronic immune checkpoint inhibitor pneumonitis
Jarushka Naidoo, Tricia R Cottrell, Evan J Lipson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
July 25, 2017
Melanoma subtypes demonstrate distinct PD-L1 expression profiles
Genevieve J Kaunitz, Tricia R Cottrell, Mohammed Lilo, et al.
Eclinicalmedicine
|
December 31, 2024
Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trial
Abha A Gupta, Anna Tinker, Derek Jonker, et al.
Journal for Immunotherapy of Cancer
|
December 25, 2025
AstroID resource: a scalable, relational database structure for longitudinal biomarker discovery
Elizabeth M Will, Benjamin F Green, Scott Carey, et al.
Page
of 4